Clinical Trials Directory

Trials / Unknown

UnknownNCT05321511

Comparison of Triggers in Double Ovarian Stimulation (DuoStim).

Double Ovarian Stimulation (DuoStim) Comparison of Triggers: Is There Any Advantage Using 3 Different Methods of Trigger for the Second Egg Collection in Predicted Low Responders?

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
165 (estimated)
Sponsor
Instituto Bernabeu · Academic / Other
Sex
Female
Age
28 Years – 43 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate the efficacy of 3 different trigggers used for final maturation in the second ovarian stimulation in double stimulation protocol (aGnRH and hCG-rec vs. aGnRH only vs. hCG-rec only). The main objective is to compare the number of all retrieved oocytes and mature oocytes in patients predicted to be low ovarian responders. This is a controlled randomized clinical study where 165 patients will be recruited.

Conditions

Interventions

TypeNameDescription
DRUGTriptorelin acetate (a-GnRH)Adminsitration of triptoreline acetate 0.2 mg for final oocyte maturation in the second ovarian stimuation inthe Double stimulation protocol.
DRUGOvitrelle® (hCG)Adminsitration of coriogonadotropine alfa 250 mcg for final oocyte maturation in the second ovarian stimuation inthe Double stimulation protocol.
DRUGDecapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used togetherAdminsitration of triptoreline acetate 0.2 mg and coriogonadotropine alfa 250 mcg for final oocyte maturation in the second ovarian stimuation inthe Double stimulation protocol.

Timeline

Start date
2022-03-03
Primary completion
2022-12-31
Completion
2023-03-31
First posted
2022-04-11
Last updated
2022-04-11

Locations

4 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT05321511. Inclusion in this directory is not an endorsement.